| scholarly article | Q13442814 |
| P953 | full work available online at | http://www.bloodjournal.org/cgi/content/abstract/78/12/3142 |
| P698 | PubMed publication ID | 1742481 |
| P2093 | author name string | G. Antonelli | |
| L. Bonomo | |||
| F. Dianzani | |||
| B. Laganà | |||
| M. Casato | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3142-3147 | |
| P577 | publication date | 1991-12-01 | |
| 1991-12-15 | |||
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia | |
| P478 | volume | 78 |
| Q40545028 | A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha |
| Q52564132 | Anti-Interferon Alpha Antibodies in Patients with High-Risk BCR/ABL-Negative Myeloproliferative Neoplasms Treated with Recombinant Human Interferon-α. |
| Q59350954 | Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis |
| Q40390091 | Clinical toxicity of the interferons. |
| Q36767655 | Cryoglobulinemia related to hepatitis C virus infection |
| Q24673191 | Cryoglobulins |
| Q42990339 | Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations |
| Q37742383 | Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience. |
| Q43038795 | Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients |
| Q42990573 | Effectiveness of leukocyte interferon-alpha treatment in patients with chronic hepatitis C not responsive to recombinant interferon |
| Q54477904 | Fatal exacerbation of hepatitis C-related cryoglobulinemia with interferon-alpha therapy |
| Q95779220 | Hepatitis C virus infection and lymphoma |
| Q34098553 | Hepatitis C virus-related lymphoproliferative disorders: an overview. |
| Q27473549 | Hepatitis C: a possible etiology for cryoglobulinaemia type II |
| Q58621898 | Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia |
| Q34375935 | Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial |
| Q37689877 | Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon |
| Q45869597 | Is interferon alpha 2b effective on cryoglobulinaemia related to hepatitis C virus? |
| Q45778438 | Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection |
| Q71594194 | Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia |
| Q36942539 | Mixed cryoglobulinemia |
| Q41519669 | Mixed cryoglobulinemia as a model of systemic vasculitis |
| Q35355811 | Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus |
| Q34579182 | Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia. |
| Q34677678 | Symptomatic cryoglobulinemia |
| Q41574278 | The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection |
| Q39806423 | Treatment of Hepatitis C Infections with Interferon: A Historical Perspective |
| Q39343958 | Treatment of hepatitis C cryoglobulinemia: mission and challenges |
| Q40733045 | [Cryoglobulinemic vasculitis]. |
Search more.